Aeolus Pharmaceuticals, Inc. (AOLS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 5, 2025
Aeolus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '17 Jun 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 | Sep '12 Sep 30, 2012 | 2007 - 2011 |
| Revenue | 0.77 | 2.08 | 3.11 | 9.63 | 3.93 | 7.29 | Upgrade
|
| Revenue Growth (YoY) | -68.71% | -33.27% | -67.70% | 145.19% | -46.14% | 51.28% | Upgrade
|
| Cost of Revenue | 2.49 | 2.88 | 3.51 | 6.97 | 3.36 | 6.47 | Upgrade
|
| Gross Profit | -1.72 | -0.81 | -0.4 | 2.67 | 0.57 | 0.83 | Upgrade
|
| Selling, General & Admin | 2.37 | 2.47 | 2.23 | 2.75 | 3.27 | 3.2 | Upgrade
|
| Operating Expenses | 2.37 | 2.47 | 2.23 | 2.75 | 3.27 | 3.2 | Upgrade
|
| Operating Income | -4.09 | -3.27 | -2.63 | -0.08 | -2.7 | -2.37 | Upgrade
|
| Interest Expense | - | -0.29 | -0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -0.51 | 4.07 | Upgrade
|
| EBT Excluding Unusual Items | -4.09 | -3.56 | -2.63 | -0.08 | -3.21 | 1.7 | Upgrade
|
| Pretax Income | -4.09 | -3.56 | -2.63 | -0.08 | -3.21 | 1.7 | Upgrade
|
| Net Income | -4.09 | -3.56 | -2.63 | -0.08 | -3.21 | 1.7 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 2.49 | - | - | - | 0.84 | Upgrade
|
| Net Income to Common | -4.09 | -6.04 | -2.63 | -0.08 | -3.21 | 0.86 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 467.89% | Upgrade
|
| Shares Outstanding (Basic) | 152 | 149 | 136 | 135 | 107 | 62 | Upgrade
|
| Shares Outstanding (Diluted) | 152 | 149 | 136 | 135 | 107 | 71 | Upgrade
|
| Shares Change (YoY) | 5.16% | 9.41% | 0.90% | 26.38% | 49.99% | -17.26% | Upgrade
|
| EPS (Basic) | -0.03 | -0.04 | -0.02 | -0.00 | -0.03 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.04 | -0.02 | -0.00 | -0.03 | -0.03 | Upgrade
|
| Free Cash Flow | -3.35 | -3.11 | -2.44 | 0.32 | -2.97 | -0.88 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | 0.00 | -0.03 | -0.01 | Upgrade
|
| Gross Margin | -223.22% | -38.78% | -12.79% | 27.67% | 14.46% | 11.31% | Upgrade
|
| Operating Margin | -531.00% | -157.66% | -84.41% | -0.83% | -68.69% | -32.51% | Upgrade
|
| Profit Margin | -531.00% | -291.14% | -84.47% | -0.83% | -81.67% | 11.74% | Upgrade
|
| Free Cash Flow Margin | -434.89% | -149.76% | -78.53% | 3.35% | -75.61% | -12.05% | Upgrade
|
| EBITDA | - | - | - | -0.07 | -2.69 | -2.36 | Upgrade
|
| EBITDA Margin | - | - | - | -0.77% | -68.53% | -32.41% | Upgrade
|
| D&A For EBITDA | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -4.09 | -3.27 | -2.63 | -0.08 | -2.7 | -2.37 | Upgrade
|
| EBIT Margin | - | -157.66% | -84.41% | -0.83% | -68.69% | -32.51% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.